Research programme: Proximity based therapeutics - InduPro
Latest Information Update: 14 Nov 2024
Price :
$50 *
At a glance
- Originator InduPro
- Class Bispecific antibodies; Drug conjugates; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 06 Sep 2024 Early research in Unspecified in USA (unspecified route) (InduPro Pipeline, September 2024)